189 related articles for article (PubMed ID: 12153470)
1. Structure/function of alpha-synuclein in health and disease: rational development of animal models for Parkinson's and related diseases.
Kahle PJ; Haass C; Kretzschmar HA; Neumann M
J Neurochem; 2002 Aug; 82(3):449-57. PubMed ID: 12153470
[No Abstract] [Full Text] [Related]
2. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.
Yamada M; Iwatsubo T; Mizuno Y; Mochizuki H
J Neurochem; 2004 Oct; 91(2):451-61. PubMed ID: 15447678
[TBL] [Abstract][Full Text] [Related]
3. The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy.
Spillantini MG; Goedert M
Ann N Y Acad Sci; 2000; 920():16-27. PubMed ID: 11193145
[TBL] [Abstract][Full Text] [Related]
4. Alpha-synuclein and neurodegenerative diseases.
Goedert M
Nat Rev Neurosci; 2001 Jul; 2(7):492-501. PubMed ID: 11433374
[No Abstract] [Full Text] [Related]
5. Alpha-synuclein has an altered conformation and shows a tight intermolecular interaction with ubiquitin in Lewy bodies.
Sharma N; McLean PJ; Kawamata H; Irizarry MC; Hyman BT
Acta Neuropathol; 2001 Oct; 102(4):329-34. PubMed ID: 11603807
[TBL] [Abstract][Full Text] [Related]
6. Extensive axonal Lewy neurites in Parkinson's disease: a novel pathological feature revealed by alpha-synuclein immunocytochemistry.
Braak H; Sandmann-Keil D; Gai W; Braak E
Neurosci Lett; 1999 Apr; 265(1):67-9. PubMed ID: 10327208
[TBL] [Abstract][Full Text] [Related]
7. Caught in the act: alpha-synuclein is the culprit in Parkinson's disease.
Eriksen JL; Dawson TM; Dickson DW; Petrucelli L
Neuron; 2003 Oct; 40(3):453-6. PubMed ID: 14642269
[TBL] [Abstract][Full Text] [Related]
8. Abeta deposition is associated with enhanced cortical alpha-synuclein lesions in Lewy body diseases.
Pletnikova O; West N; Lee MK; Rudow GL; Skolasky RL; Dawson TM; Marsh L; Troncoso JC
Neurobiol Aging; 2005; 26(8):1183-92. PubMed ID: 15917102
[TBL] [Abstract][Full Text] [Related]
9. Alpha-synuclein and Parkinson's disease.
Golbe LI
Adv Neurol; 2003; 91():165-74. PubMed ID: 12442675
[No Abstract] [Full Text] [Related]
10. Cellular co-localization of phosphorylated tau- and NACP/alpha-synuclein-epitopes in lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies.
Arima K; Hirai S; Sunohara N; Aoto K; Izumiyama Y; Uéda K; Ikeda K; Kawai M
Brain Res; 1999 Oct; 843(1-2):53-61. PubMed ID: 10528110
[TBL] [Abstract][Full Text] [Related]
11. Challenges and complexities of alpha-synuclein toxicity: new postulates in unfolding the mystery associated with Parkinson's disease.
Hegde ML; Jagannatha Rao KS
Arch Biochem Biophys; 2003 Oct; 418(2):169-78. PubMed ID: 14522588
[TBL] [Abstract][Full Text] [Related]
12. Clusterin/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with alpha-synucleinopathies.
Sasaki K; Doh-ura K; Wakisaka Y; Iwaki T
Acta Neuropathol; 2002 Sep; 104(3):225-30. PubMed ID: 12172907
[TBL] [Abstract][Full Text] [Related]
13. Aggregation of alpha-synuclein in the pathogenesis of Parkinson's disease.
Iwatsubo T
J Neurol; 2003 Oct; 250 Suppl 3():III11-4. PubMed ID: 14579119
[TBL] [Abstract][Full Text] [Related]
14. [Parkinson's disease, dementia with Lewy bodies, multiple system atrophy and alpha-synuclein].
Iwatsubo T
Rinsho Shinkeigaku; 1999 Dec; 39(12):1285-6. PubMed ID: 10791099
[TBL] [Abstract][Full Text] [Related]
15. Synphilin-1 is present in Lewy bodies in Parkinson's disease.
Wakabayashi K; Engelender S; Yoshimoto M; Tsuji S; Ross CA; Takahashi H
Ann Neurol; 2000 Apr; 47(4):521-3. PubMed ID: 10762166
[TBL] [Abstract][Full Text] [Related]
16. Lipid droplet binding and oligomerization properties of the Parkinson's disease protein alpha-synuclein.
Cole NB; Murphy DD; Grider T; Rueter S; Brasaemle D; Nussbaum RL
J Biol Chem; 2002 Feb; 277(8):6344-52. PubMed ID: 11744721
[TBL] [Abstract][Full Text] [Related]
17. Aggresomes formed by alpha-synuclein and synphilin-1 are cytoprotective.
Tanaka M; Kim YM; Lee G; Junn E; Iwatsubo T; Mouradian MM
J Biol Chem; 2004 Feb; 279(6):4625-31. PubMed ID: 14627698
[TBL] [Abstract][Full Text] [Related]
18. alpha-Synuclein forms a complex with transcription factor Elk-1.
Iwata A; Miura S; Kanazawa I; Sawada M; Nukina N
J Neurochem; 2001 Apr; 77(1):239-52. PubMed ID: 11279280
[TBL] [Abstract][Full Text] [Related]
19. Accumulation of NACP/alpha-synuclein in lewy body disease and multiple system atrophy.
Shoji M; Harigaya Y; Sasaki A; Uéda K; Ishiguro K; Matsubara E; Watanabe M; Ikeda M; Kanai M; Tomidokoro Y; Shizuka M; Amari M; Kosaka K; Nakazato Y; Okamoto K; Hirai S
J Neurol Neurosurg Psychiatry; 2000 May; 68(5):605-8. PubMed ID: 10766891
[TBL] [Abstract][Full Text] [Related]
20. Colocalization of tau and alpha-synuclein epitopes in Lewy bodies.
Ishizawa T; Mattila P; Davies P; Wang D; Dickson DW
J Neuropathol Exp Neurol; 2003 Apr; 62(4):389-97. PubMed ID: 12722831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
